Jake Xia
Director/Board Member at Hangzhou Qihan Biotech Co., Ltd.
Profile
Ji Qing Xia is currently a Director at Hangzhou Qihan Biotech Co., Ltd.
Prior to this, he held positions as Managing Director & Chief Risk Officer at Harvard Management Co., Inc., Vice President at Salomon Brothers, and Principal at Morgan Stanley Capital Partners (Private Equity).
He received his undergraduate degree from Peking University, his doctorate from Massachusetts Institute of Technology, and his graduate degree from Northeastern University.
Jake Xia active positions
| Companies | Position | Start |
|---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Director/Board Member | - |
Former positions of Jake Xia
| Companies | Position | End |
|---|---|---|
| Salomon Brothers | Corporate Officer/Principal | - |
Morgan Stanley Capital Partners (Private Equity)
 Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Training of Jake Xia
| Massachusetts Institute of Technology | Doctorate Degree |
| Northeastern University | Graduate Degree |
| Peking University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
| Salomon Brothers | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
- Stock Market
- Insiders
- Jake Xia
